Real-life Use of Cefazolin for the Treatment of Meticillin-susceptible Staphylococcal Infective Endocarditis: Comparison to a Treatment Cohort With Penicillin M
CompletedOBSERVATIONAL
Enrollment
192
Participants
Timeline
Start Date
February 5, 2020
Primary Completion Date
March 31, 2022
Study Completion Date
March 31, 2022
Conditions
Infectious DiseaseEndocarditis
Trial Locations (1)
74374
Centre Hospitalier Annecy Genevois, Metz-Tessy
All Listed Sponsors
lead
Centre Hospitalier Annecy Genevois
OTHER
NCT05474118 - Real-life Use of Cefazolin for the Treatment of Meticillin-susceptible Staphylococcal Infective Endocarditis: Comparison to a Treatment Cohort With Penicillin M | Biotech Hunter | Biotech Hunter